Thomas E. Callis

6.9k citations

26 papers · 5.3k indexed · 2 hit papers · h-index 20

Impact in

Cancer Research top 0.2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Molecular Biology top 1%
- Circular RNAs in diseases
- RNA Research and Splicing
- Muscle Physiology and Disorders
- RNA modifications and cancer
- RNA Interference and Gene Delivery
- Congenital heart defects research

Papers in ⓘ

Cancer Research 11
- MicroRNA in disease regulation 10
Cardiology and Cardiovascular Medicine 12
- Cardiac electrophysiology and arrhythmias 6
- Cardiomyopathy and Myosin Studies 5

Co-authors: Jian‐Fu Chen (7 shared papers)Da‐Zhi Wang (6 shared papers)Scott M. Hammond (3 shared papers)J. Michael Thomson (2 shared papers)Frank L. Conlon (4 shared papers)Elizabeth M. Mandel (4 shared papers)Da‐Zhi Wang (7 shared papers)Mariko Tatsuguchi (4 shared papers)
Journals: JAMA Cardiology (2 papers)Journal of Cardiovascular Translational Research (2 papers)Proceedings of the National Academy of Sciences (2 papers)Circulation Genomic and Precision Medicine (2 papers)Nature Genetics (1 paper)
Partner nations: United States Netherlands China

In The Last Decade

Thomas E. Callis

26 papers receiving 5.2k citations

Hit Papers

align trajectories log scale

MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice 2009 · 679 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2009 Journal of Clinical Investigation
2005 Nature Genetics

Peers

Countries citing papers authored by Thomas E. Callis

Since Specialization

Citations

This map shows the geographic impact of Thomas E. Callis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Callis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Callis more than expected).

Fields of papers citing papers by Thomas E. Callis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas E. Callis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Callis. The network helps show where Thomas E. Callis may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas E. Callis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas E. Callis Line = papers co-authored together Thomas E. Callis links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation Nature Genetics ·Jian‐Fu Chen, Elizabeth M. Mandel, J. Michael Thomson, Qiulian Wu, Thomas E. Callis, Scott M. Hammond, Frank L. Conlon, Da‐Zhi Wang Hit paper breakdown →	2005	2258
2	MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice Journal of Clinical Investigation ·Thomas E. Callis, Kumar Pandya, Heeyoung Seok, Ruhang Tang, Mariko Tatsuguchi, Zhan‐Peng Huang, Jian‐Fu Chen, Zhong‐Liang Deng, Bronwyn M. Gunn, Janelle Shumate, Monte S. Willis, Craig H. Selzman, Dazhi Wang Hit paper breakdown →	2009	679
3	Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure Proceedings of the National Academy of Sciences ·Jian‐Fu Chen, Elizabeth P. Murchison, Ruhang Tang, Thomas E. Callis, Mariko Tatsuguchi, Zhong‐Liang Deng, Mauricio Rojas, Scott M. Hammond, Michael Schneider, Craig H. Selzman, Gerhard Meissner, Cam Patterson, Gregory J. Hannon, Da‐Zhi Wang	2008	453
4	Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy Journal of Molecular and Cellular Cardiology ·Mariko Tatsuguchi, Heeyoung Seok, Thomas E. Callis, J. Michael Thomson, Jian‐Fu Chen, Martin A. Newman, Mauricio Rojas, Scott M. Hammond, Da‐Zhi Wang	2007	361
5	MicroRNAs 1, 133, and 206: Critical factors of skeletal and cardiac muscle development, function, and disease The International Journal of Biochemistry & Cell Biology ·W. H. Davin Townley-Tilson, Thomas E. Callis, Da‐Zhi Wang	2009	298
6	Distinguishing Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia–Associated Mutations From Background Genetic Noise Journal of the American College of Cardiology ·Jamie D. Kapplinger, Andrew P. Landstrom, Benjamin A. Salisbury, Thomas E. Callis, Guido D. Pollevick, David J. Tester, Moniek G.P.J. Cox, Zahir A. Bhuiyan, Hennie Bikker, Ans C.P. Wiesfeld, Richard N.W. Hauer, J. Peter van Tintelen, Jan D.H. Jongbloed, Hugh Calkins, Daniel P. Judge, Arthur A.M. Wilde, Michael J. Ackerman	2011	210
7	MicroRNAs in Skeletal and Cardiac Muscle Development DNA and Cell Biology ·Thomas E. Callis, Jian‐Fu Chen, Da‐Zhi Wang	2007	140
8	microRNAs and muscle disorders Journal of Cell Science ·Jian‐Fu Chen, Thomas E. Callis, Da‐Zhi Wang	2008	124
9	Muscling Through the microRNA World Experimental Biology and Medicine ·Thomas E. Callis, Zhong‐Liang Deng, Jian‐Fu Chen, Da‐Zhi Wang	2008	110
10	Myocardin inhibits cellular proliferation by inhibiting NF-κB(p65)-dependent cell cycle progression Proceedings of the National Academy of Sciences ·Ruhang Tang, Xi‐Long Zheng, Thomas E. Callis, William E. Stansfield, Jia-Yin He, Albert S. Baldwin, Da‐Zhi Wang, Craig H. Selzman	2008	97
11	Taking microRNAs to heart Trends in Molecular Medicine ·Thomas E. Callis, Da‐Zhi Wang	2008	92
12	miR-155 Inhibits Expression of the MEF2A Protein to Repress Skeletal Muscle Differentiation Journal of Biological Chemistry ·Heeyoung Seok, Mariko Tatsuguchi, Thomas E. Callis, Aibin He, William T. Pu, Da‐Zhi Wang	2011	81
13	Enhanced Classification of Brugada Syndrome–Associated and Long-QT Syndrome–Associated Genetic Variants in the SCN5A -Encoded Na _v 1.5 Cardiac Sodium Channel Circulation Cardiovascular Genetics ·Jamie D. Kapplinger, John R. Giudicessi, Dan Ye, David J. Tester, Thomas E. Callis, Carmen R. Valdivia, Jonathan C. Makielski, Arthur A.M. Wilde, Michael J. Ackerman	2015	71
14	The BMP pathway acts to directly regulate Tbx20 in the developing heart Development ·Elizabeth M. Mandel, Erin Kaltenbrun, Thomas E. Callis, Xin-Xin I. Zeng, Sara R. Marques, Deborah Yelon, Da‐Zhi Wang, Frank L. Conlon	2010	45
15	Bone Morphogenetic Protein Signaling Modulates Myocardin Transactivation of Cardiac Genes Circulation Research ·Thomas E. Callis, Dongsun Cao, Da‐Zhi Wang	2005	43
16	Distinguishing Hypertrophic Cardiomyopathy-Associated Mutations from Background Genetic Noise Journal of Cardiovascular Translational Research ·Jamie D. Kapplinger, Andrew P. Landstrom, J. Martijn Bos, Benjamin A. Salisbury, Thomas E. Callis, Michael J. Ackerman	2014	39
17	Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinoma Genetics in Medicine ·Amin H. Nassar, Sarah Abou Alaiwi, Saud H. AlDubayan, Nicholas Moore, Kent W. Mouw, David J. Kwiatkowski, Toni K. Choueiri, Catherine Curran, Jacob E. Berchuck, Lauren C. Harshman, Pier Vitale Nuzzo, Nieves Martínez Chanzá, Eliezer M. Van Allen, Edward D. Esplin, Shan Yang, Thomas E. Callis, Judy E. Garber, Huma Q. Rana, Guru Sonpavde	2019	38
18	Assessment of the Diagnostic Yield of Combined Cardiomyopathy and Arrhythmia Genetic Testing JAMA Cardiology ·Lisa Dellefave‐Castillo, Allison L. Cirino, Thomas E. Callis, Edward D. Esplin, John Garcia, Kathryn E. Hatchell, Britt Johnson, Ana Morales, Ellen S. Regalado, Susan Rojahn, Matteo Vatta, Robert L. Nussbaum, Elizabeth M. McNally	2022	36
19	Evolving molecular diagnostics for familial cardiomyopathies: at the heart of it all Expert Review of Molecular Diagnostics ·Thomas E. Callis, Brian C. Jensen, Karen E. Weck, Monte S. Willis	2010	26
20	Yield of the RYR2 Genetic Test in Suspected Catecholaminergic Polymorphic Ventricular Tachycardia and Implications for Test Interpretation Circulation Genomic and Precision Medicine ·Jamie D. Kapplinger, Krishna Pundi, Nicholas B. Larson, Thomas E. Callis, David J. Tester, Hennie Bikker, Arthur A.M. Wilde, Michael J. Ackerman	2018	24

About Thomas E. Callis

Thomas E. Callis is a scholar working on Cancer Research, Cardiology and Cardiovascular Medicine, Molecular Biology, Genetics and Orthopedics and Sports Medicine, having authored 26 papers that have together received 5.3k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (10 papers), Circular RNAs in diseases (8 papers), Cardiac electrophysiology and arrhythmias (6 papers), Congenital heart defects research (6 papers), Cardiomyopathy and Myosin Studies (5 papers), RNA Research and Splicing (5 papers), RNA modifications and cancer (5 papers) and RNA and protein synthesis mechanisms (3 papers). The work is most often cited by research in Cancer Research (3.3k citations), Molecular Biology (4.2k citations), Cardiology and Cardiovascular Medicine (836 citations), Genetics (156 citations) and Aging (24 citations). Thomas E. Callis has collaborated with scholars based in United States, Netherlands and China. Frequent co-authors include Jian‐Fu Chen, Da‐Zhi Wang, Scott M. Hammond, J. Michael Thomson, Frank L. Conlon, Elizabeth M. Mandel, Da‐Zhi Wang, Mariko Tatsuguchi, Zhong‐Liang Deng and Heeyoung Seok. Their work appears in journals such as JAMA Cardiology, Journal of Cardiovascular Translational Research, Proceedings of the National Academy of Sciences, Circulation Genomic and Precision Medicine and Nature Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact